Connection

Perry Halushka to Cyclic Nucleotide Phosphodiesterases, Type 3

Back to Details
This is a "connection" page, showing publications Perry Halushka has written about Cyclic Nucleotide Phosphodiesterases, Type 3.
Perry Halushka
Connection Strength
0.013
Cyclic Nucleotide Phosphodiesterases, Type 3
  1. Pharmacology of a new cyclic nucleotide phosphodiesterase type 4 inhibitor, V11294. Pulm Pharmacol Ther. 2003; 16(2):97-104.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.